- call +1-201-465-4211
- email sales@marketsandresearch.biz
- Call +1-201-465-4211
- Email: sales@marketsandresearch.biz
The Pirfenidone market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our latest study, due to COVID-19 pandemic, the global Pirfenidone market size is estimated to be worth US$ million in 2021 and is forecast to a readjusted size of USD million by 2028 with a CAGR of % during review period. Mild Idiopathic Pulmonary Fibrosis accounting for % of the Pirfenidone global market in 2021, is projected to value USD million by 2028, growing at a % CAGR in next six years. While Tablet segment is altered to a % CAGR between 2022 and 2028.
Global key manufacturers of Pirfenidone include Genentech (Roche), Shionogi, GNI Group, Beijing Continent, and Cipla, etc. In terms of revenue, the global top four players hold a share over % in 2021.
Market segmentation
Pirfenidone market is split by Type and by Application. For the period 2017-2028, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
Tablet
Capsule
Other
Market segment by Application can be divided into
Mild Idiopathic Pulmonary Fibrosis
Moderate Idiopathic Pulmonary Fibrosis
Other
The key market players for global Pirfenidone market are listed below:
Genentech (Roche)
Shionogi
GNI Group
Beijing Continent
Cipla
Lupin Ltd
Zydus Cadila
Glenmark Pharmaceuticals
Koye Pharmaceuticals
MSN Laboratories
Wockhardt
Incepta Pharmaceuticals
Unimed Unihealth
Market segment by region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Pirfenidone product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Pirfenidone, with price, sales, revenue and global market share of Pirfenidone from 2019 to 2022.
Chapter 3, the Pirfenidone competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Pirfenidone breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2017 to 2028.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2017 to 2028.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2017 to 2022.and Pirfenidone market forecast, by regions, type and application, with sales and revenue, from 2023 to 2028.
Chapter 12, the key raw materials and key suppliers, and industry chain of Pirfenidone.
Chapter 13, 14, and 15, to describe Pirfenidone sales channel, distributors, customers, research findings and conclusion, appendix and data source.
The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.
Market is segmented on the basis:
The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.
The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.
1 Market Overview
1.1 Pirfenidone Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Pirfenidone Revenue by Type: 2017 Versus 2021 Versus 2028
1.2.2 Tablet
1.2.3 Capsule
1.2.4 Other
1.3 Market Analysis by Application
1.3.1 Overview: Global Pirfenidone Revenue by Application: 2017 Versus 2021 Versus 2028
1.3.2 Mild Idiopathic Pulmonary Fibrosis
1.3.3 Moderate Idiopathic Pulmonary Fibrosis
1.3.4 Other
1.4 Global Pirfenidone Market Size & Forecast
1.4.1 Global Pirfenidone Sales in Value (2017 & 2021 & 2028)
1.4.2 Global Pirfenidone Sales in Volume (2017-2028)
1.4.3 Global Pirfenidone Price (2017-2028)
1.5 Global Pirfenidone Production Capacity Analysis
1.5.1 Global Pirfenidone Total Production Capacity (2017-2028)
1.5.2 Global Pirfenidone Production Capacity by Geographic Region
1.6 Market Drivers, Restraints and Trends
1.6.1 Pirfenidone Market Drivers
1.6.2 Pirfenidone Market Restraints
1.6.3 Pirfenidone Trends Analysis
2 Manufacturers Profiles
2.1 Genentech (Roche)
2.1.1 Genentech (Roche) Details
2.1.2 Genentech (Roche) Major Business
2.1.3 Genentech (Roche) Pirfenidone Product and Services
2.1.4 Genentech (Roche) Pirfenidone Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.2 Shionogi
2.2.1 Shionogi Details
2.2.2 Shionogi Major Business
2.2.3 Shionogi Pirfenidone Product and Services
2.2.4 Shionogi Pirfenidone Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.3 GNI Group
2.3.1 GNI Group Details
2.3.2 GNI Group Major Business
2.3.3 GNI Group Pirfenidone Product and Services
2.3.4 GNI Group Pirfenidone Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.4 Beijing Continent
2.4.1 Beijing Continent Details
2.4.2 Beijing Continent Major Business
2.4.3 Beijing Continent Pirfenidone Product and Services
2.4.4 Beijing Continent Pirfenidone Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.5 Cipla
2.5.1 Cipla Details
2.5.2 Cipla Major Business
2.5.3 Cipla Pirfenidone Product and Services
2.5.4 Cipla Pirfenidone Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.6 Lupin Ltd
2.6.1 Lupin Ltd Details
2.6.2 Lupin Ltd Major Business
2.6.3 Lupin Ltd Pirfenidone Product and Services
2.6.4 Lupin Ltd Pirfenidone Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.7 Zydus Cadila
2.7.1 Zydus Cadila Details
2.7.2 Zydus Cadila Major Business
2.7.3 Zydus Cadila Pirfenidone Product and Services
2.7.4 Zydus Cadila Pirfenidone Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.8 Glenmark Pharmaceuticals
2.8.1 Glenmark Pharmaceuticals Details
2.8.2 Glenmark Pharmaceuticals Major Business
2.8.3 Glenmark Pharmaceuticals Pirfenidone Product and Services
2.8.4 Glenmark Pharmaceuticals Pirfenidone Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.9 Koye Pharmaceuticals
2.9.1 Koye Pharmaceuticals Details
2.9.2 Koye Pharmaceuticals Major Business
2.9.3 Koye Pharmaceuticals Pirfenidone Product and Services
2.9.4 Koye Pharmaceuticals Pirfenidone Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.10 MSN Laboratories
2.10.1 MSN Laboratories Details
2.10.2 MSN Laboratories Major Business
2.10.3 MSN Laboratories Pirfenidone Product and Services
2.10.4 MSN Laboratories Pirfenidone Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.11 Wockhardt
2.11.1 Wockhardt Details
2.11.2 Wockhardt Major Business
2.11.3 Wockhardt Pirfenidone Product and Services
2.11.4 Wockhardt Pirfenidone Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.12 Incepta Pharmaceuticals
2.12.1 Incepta Pharmaceuticals Details
2.12.2 Incepta Pharmaceuticals Major Business
2.12.3 Incepta Pharmaceuticals Pirfenidone Product and Services
2.12.4 Incepta Pharmaceuticals Pirfenidone Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.13 Unimed Unihealth
2.13.1 Unimed Unihealth Details
2.13.2 Unimed Unihealth Major Business
2.13.3 Unimed Unihealth Pirfenidone Product and Services
2.13.4 Unimed Unihealth Pirfenidone Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
3 Pirfenidone Breakdown Data by Manufacturer
3.1 Global Pirfenidone Sales in Volume by Manufacturer (2019, 2020, 2021, and 2022)
3.2 Global Pirfenidone Revenue by Manufacturer (2019, 2020, 2021, and 2022)
3.3 Key Manufacturer Market Position in Pirfenidone
3.4 Market Concentration Rate
3.4.1 Top 3 Pirfenidone Manufacturer Market Share in 2021
3.4.2 Top 6 Pirfenidone Manufacturer Market Share in 2021
3.5 Global Pirfenidone Production Capacity by Company: 2021 VS 2022
3.6 Manufacturer by Geography: Head Office and Pirfenidone Production Site
3.7 New Entrant and Capacity Expansion Plans
3.8 Mergers & Acquisitions
4 Market Analysis by Region
4.1 Global Pirfenidone Market Size by Region
4.1.1 Global Pirfenidone Sales in Volume by Region (2017-2028)
4.1.2 Global Pirfenidone Revenue by Region (2017-2028)
4.2 North America Pirfenidone Revenue (2017-2028)
4.3 Europe Pirfenidone Revenue (2017-2028)
4.4 Asia-Pacific Pirfenidone Revenue (2017-2028)
4.5 South America Pirfenidone Revenue (2017-2028)
4.6 Middle East and Africa Pirfenidone Revenue (2017-2028)
5 Market Segment by Type
5.1 Global Pirfenidone Sales in Volume by Type (2017-2028)
5.2 Global Pirfenidone Revenue by Type (2017-2028)
5.3 Global Pirfenidone Price by Type (2017-2028)
6 Market Segment by Application
6.1 Global Pirfenidone Sales in Volume by Application (2017-2028)
6.2 Global Pirfenidone Revenue by Application (2017-2028)
6.3 Global Pirfenidone Price by Application (2017-2028)
7 North America by Country, by Type, and by Application
7.1 North America Pirfenidone Sales by Type (2017-2028)
7.2 North America Pirfenidone Sales by Application (2017-2028)
7.3 North America Pirfenidone Market Size by Country
7.3.1 North America Pirfenidone Sales in Volume by Country (2017-2028)
7.3.2 North America Pirfenidone Revenue by Country (2017-2028)
7.3.3 United States Market Size and Forecast (2017-2028)
7.3.4 Canada Market Size and Forecast (2017-2028)
7.3.5 Mexico Market Size and Forecast (2017-2028)
8 Europe by Country, by Type, and by Application
8.1 Europe Pirfenidone Sales by Type (2017-2028)
8.2 Europe Pirfenidone Sales by Application (2017-2028)
8.3 Europe Pirfenidone Market Size by Country
8.3.1 Europe Pirfenidone Sales in Volume by Country (2017-2028)
8.3.2 Europe Pirfenidone Revenue by Country (2017-2028)
8.3.3 Germany Market Size and Forecast (2017-2028)
8.3.4 France Market Size and Forecast (2017-2028)
8.3.5 United Kingdom Market Size and Forecast (2017-2028)
8.3.6 Russia Market Size and Forecast (2017-2028)
8.3.7 Italy Market Size and Forecast (2017-2028)
9 Asia-Pacific by Region, by Type, and by Application
9.1 Asia-Pacific Pirfenidone Sales by Type (2017-2028)
9.2 Asia-Pacific Pirfenidone Sales by Application (2017-2028)
9.3 Asia-Pacific Pirfenidone Market Size by Region
9.3.1 Asia-Pacific Pirfenidone Sales in Volume by Region (2017-2028)
9.3.2 Asia-Pacific Pirfenidone Revenue by Region (2017-2028)
9.3.3 China Market Size and Forecast (2017-2028)
9.3.4 Japan Market Size and Forecast (2017-2028)
9.3.5 Korea Market Size and Forecast (2017-2028)
9.3.6 India Market Size and Forecast (2017-2028)
9.3.7 Southeast Asia Market Size and Forecast (2017-2028)
9.3.8 Australia Market Size and Forecast (2017-2028)
10 South America by Region, by Type, and by Application
10.1 South America Pirfenidone Sales by Type (2017-2028)
10.2 South America Pirfenidone Sales by Application (2017-2028)
10.3 South America Pirfenidone Market Size by Country
10.3.1 South America Pirfenidone Sales in Volume by Country (2017-2028)
10.3.2 South America Pirfenidone Revenue by Country (2017-2028)
10.3.3 Brazil Market Size and Forecast (2017-2028)
10.3.4 Argentina Market Size and Forecast (2017-2028)
11 Middle East & Africa by Country, by Type, and by Application
11.1 Middle East & Africa Pirfenidone Sales by Type (2017-2028)
11.2 Middle East & Africa Pirfenidone Sales by Application (2017-2028)
11.3 Middle East & Africa Pirfenidone Market Size by Country
11.3.1 Middle East & Africa Pirfenidone Sales in Volume by Country (2017-2028)
11.3.2 Middle East & Africa Pirfenidone Revenue by Country (2017-2028)
11.3.3 Turkey Market Size and Forecast (2017-2028)
11.3.4 Egypt Market Size and Forecast (2017-2028)
11.3.5 Saudi Arabia Market Size and Forecast (2017-2028)
11.3.6 South Africa Market Size and Forecast (2017-2028)
12 Raw Material and Industry Chain
12.1 Raw Material of Pirfenidone and Key Manufacturers
12.2 Manufacturing Costs Percentage of Pirfenidone
12.3 Pirfenidone Production Process
12.4 Pirfenidone Industrial Chain
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.2 Pirfenidone Typical Distributors
13.3 Pirfenidone Typical Customers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Research Process and Data Source
15.3 Disclaimer
List of Tables
Table 1. Global Pirfenidone Revenue by Type, (USD Million), 2017 & 2021 & 2028
Table 2. Global Pirfenidone Revenue by Application, (USD Million), 2017 & 2021 & 2028
Table 3. Genentech (Roche) Basic Information, Manufacturing Base and Competitors
Table 4. Genentech (Roche) Major Business
Table 5. Genentech (Roche) Pirfenidone Product and Services
Table 6. Genentech (Roche) Pirfenidone Sales (K Pcs), Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 7. Shionogi Basic Information, Manufacturing Base and Competitors
Table 8. Shionogi Major Business
Table 9. Shionogi Pirfenidone Product and Services
Table 10. Shionogi Pirfenidone Sales (K Pcs), Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 11. GNI Group Basic Information, Manufacturing Base and Competitors
Table 12. GNI Group Major Business
Table 13. GNI Group Pirfenidone Product and Services
Table 14. GNI Group Pirfenidone Sales (K Pcs), Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 15. Beijing Continent Basic Information, Manufacturing Base and Competitors
Table 16. Beijing Continent Major Business
Table 17. Beijing Continent Pirfenidone Product and Services
Table 18. Beijing Continent Pirfenidone Sales (K Pcs), Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 19. Cipla Basic Information, Manufacturing Base and Competitors
Table 20. Cipla Major Business
Table 21. Cipla Pirfenidone Product and Services
Table 22. Cipla Pirfenidone Sales (K Pcs), Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 23. Lupin Ltd Basic Information, Manufacturing Base and Competitors
Table 24. Lupin Ltd Major Business
Table 25. Lupin Ltd Pirfenidone Product and Services
Table 26. Lupin Ltd Pirfenidone Sales (K Pcs), Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 27. Zydus Cadila Basic Information, Manufacturing Base and Competitors
Table 28. Zydus Cadila Major Business
Table 29. Zydus Cadila Pirfenidone Product and Services
Table 30. Zydus Cadila Pirfenidone Sales (K Pcs), Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 31. Glenmark Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 32. Glenmark Pharmaceuticals Major Business
Table 33. Glenmark Pharmaceuticals Pirfenidone Product and Services
Table 34. Glenmark Pharmaceuticals Pirfenidone Sales (K Pcs), Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 35. Koye Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 36. Koye Pharmaceuticals Major Business
Table 37. Koye Pharmaceuticals Pirfenidone Product and Services
Table 38. Koye Pharmaceuticals Pirfenidone Sales (K Pcs), Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 39. MSN Laboratories Basic Information, Manufacturing Base and Competitors
Table 40. MSN Laboratories Major Business
Table 41. MSN Laboratories Pirfenidone Product and Services
Table 42. MSN Laboratories Pirfenidone Sales (K Pcs), Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 43. Wockhardt Basic Information, Manufacturing Base and Competitors
Table 44. Wockhardt Major Business
Table 45. Wockhardt Pirfenidone Product and Services
Table 46. Wockhardt Pirfenidone Sales (K Pcs), Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 47. Incepta Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 48. Incepta Pharmaceuticals Major Business
Table 49. Incepta Pharmaceuticals Pirfenidone Product and Services
Table 50. Incepta Pharmaceuticals Pirfenidone Sales (K Pcs), Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 51. Unimed Unihealth Basic Information, Manufacturing Base and Competitors
Table 52. Unimed Unihealth Major Business
Table 53. Unimed Unihealth Pirfenidone Product and Services
Table 54. Unimed Unihealth Pirfenidone Sales (K Pcs), Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 55. Global Pirfenidone Sales by Manufacturer (2019, 2020, 2021, and 2022) & (K Pcs)
Table 56. Global Pirfenidone Revenue by Manufacturer (2019, 2020, 2021, and 2022) & (USD Million)
Table 57. Market Position of Manufacturers in Pirfenidone, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2021
Table 58. Global Pirfenidone Production Capacity by Company, (K Pcs): 2020 VS 2021
Table 59. Head Office and Pirfenidone Production Site of Key Manufacturer
Table 60. Pirfenidone New Entrant and Capacity Expansion Plans
Table 61. Pirfenidone Mergers & Acquisitions in the Past Five Years
Table 62. Global Pirfenidone Sales by Region (2017-2022) & (K Pcs)
Table 63. Global Pirfenidone Sales by Region (2023-2028) & (K Pcs)
Table 64. Global Pirfenidone Revenue by Region (2017-2022) & (USD Million)
Table 65. Global Pirfenidone Revenue by Region (2023-2028) & (USD Million)
Table 66. Global Pirfenidone Sales by Type (2017-2022) & (K Pcs)
Table 67. Global Pirfenidone Sales by Type (2023-2028) & (K Pcs)
Table 68. Global Pirfenidone Revenue by Type (2017-2022) & (USD Million)
Table 69. Global Pirfenidone Revenue by Type (2023-2028) & (USD Million)
Table 70. Global Pirfenidone Price by Type (2017-2022) & (USD/Pcs)
Table 71. Global Pirfenidone Price by Type (2023-2028) & (USD/Pcs)
Table 72. Global Pirfenidone Sales by Application (2017-2022) & (K Pcs)
Table 73. Global Pirfenidone Sales by Application (2023-2028) & (K Pcs)
Table 74. Global Pirfenidone Revenue by Application (2017-2022) & (USD Million)
Table 75. Global Pirfenidone Revenue by Application (2023-2028) & (USD Million)
Table 76. Global Pirfenidone Price by Application (2017-2022) & (USD/Pcs)
Table 77. Global Pirfenidone Price by Application (2023-2028) & (USD/Pcs)
Table 78. North America Pirfenidone Sales by Country (2017-2022) & (K Pcs)
Table 79. North America Pirfenidone Sales by Country (2023-2028) & (K Pcs)
Table 80. North America Pirfenidone Revenue by Country (2017-2022) & (USD Million)
Table 81. North America Pirfenidone Revenue by Country (2023-2028) & (USD Million)
Table 82. North America Pirfenidone Sales by Type (2017-2022) & (K Pcs)
Table 83. North America Pirfenidone Sales by Type (2023-2028) & (K Pcs)
Table 84. North America Pirfenidone Sales by Application (2017-2022) & (K Pcs)
Table 85. North America Pirfenidone Sales by Application (2023-2028) & (K Pcs)
Table 86. Europe Pirfenidone Sales by Country (2017-2022) & (K Pcs)
Table 87. Europe Pirfenidone Sales by Country (2023-2028) & (K Pcs)
Table 88. Europe Pirfenidone Revenue by Country (2017-2022) & (USD Million)
Table 89. Europe Pirfenidone Revenue by Country (2023-2028) & (USD Million)
Table 90. Europe Pirfenidone Sales by Type (2017-2022) & (K Pcs)
Table 91. Europe Pirfenidone Sales by Type (2023-2028) & (K Pcs)
Table 92. Europe Pirfenidone Sales by Application (2017-2022) & (K Pcs)
Table 93. Europe Pirfenidone Sales by Application (2023-2028) & (K Pcs)
Table 94. Asia-Pacific Pirfenidone Sales by Region (2017-2022) & (K Pcs)
Table 95. Asia-Pacific Pirfenidone Sales by Region (2023-2028) & (K Pcs)
Table 96. Asia-Pacific Pirfenidone Revenue by Region (2017-2022) & (USD Million)
Table 97. Asia-Pacific Pirfenidone Revenue by Region (2023-2028) & (USD Million)
Table 98. Asia-Pacific Pirfenidone Sales by Type (2017-2022) & (K Pcs)
Table 99. Asia-Pacific Pirfenidone Sales by Type (2023-2028) & (K Pcs)
Table 100. Asia-Pacific Pirfenidone Sales by Application (2017-2022) & (K Pcs)
Table 101. Asia-Pacific Pirfenidone Sales by Application (2023-2028) & (K Pcs)
Table 102. South America Pirfenidone Sales by Country (2017-2022) & (K Pcs)
Table 103. South America Pirfenidone Sales by Country (2023-2028) & (K Pcs)
Table 104. South America Pirfenidone Revenue by Country (2017-2022) & (USD Million)
Table 105. South America Pirfenidone Revenue by Country (2023-2028) & (USD Million)
Table 106. South America Pirfenidone Sales by Type (2017-2022) & (K Pcs)
Table 107. South America Pirfenidone Sales by Type (2023-2028) & (K Pcs)
Table 108. South America Pirfenidone Sales by Application (2017-2022) & (K Pcs)
Table 109. South America Pirfenidone Sales by Application (2023-2028) & (K Pcs)
Table 110. Middle East & Africa Pirfenidone Sales by Region (2017-2022) & (K Pcs)
Table 111. Middle East & Africa Pirfenidone Sales by Region (2023-2028) & (K Pcs)
Table 112. Middle East & Africa Pirfenidone Revenue by Region (2017-2022) & (USD Million)
Table 113. Middle East & Africa Pirfenidone Revenue by Region (2023-2028) & (USD Million)
Table 114. Middle East & Africa Pirfenidone Sales by Type (2017-2022) & (K Pcs)
Table 115. Middle East & Africa Pirfenidone Sales by Type (2023-2028) & (K Pcs)
Table 116. Middle East & Africa Pirfenidone Sales by Application (2017-2022) & (K Pcs)
Table 117. Middle East & Africa Pirfenidone Sales by Application (2023-2028) & (K Pcs)
Table 118. Pirfenidone Raw Material
Table 119. Key Manufacturers of Pirfenidone Raw Materials
Table 120. Direct Channel Pros & Cons
Table 121. Indirect Channel Pros & Cons
Table 122. Pirfenidone Typical Distributors
Table 123. Pirfenidone Typical Customers
List of Figures
Figure 1. Pirfenidone Picture
Figure 2. Global Pirfenidone Revenue Market Share by Type in 2021
Figure 3. Tablet
Figure 4. Capsule
Figure 5. Other
Figure 6. Global Pirfenidone Revenue Market Share by Application in 2021
Figure 7. Mild Idiopathic Pulmonary Fibrosis
Figure 8. Moderate Idiopathic Pulmonary Fibrosis
Figure 9. Other
Figure 10. Global Pirfenidone Revenue, (USD Million) & (K Pcs): 2017 & 2021 & 2028
Figure 11. Global Pirfenidone Revenue and Forecast (2017-2028) & (USD Million)
Figure 12. Global Pirfenidone Sales (2017-2028) & (K Pcs)
Figure 13. Global Pirfenidone Price (2017-2028) & (USD/Pcs)
Figure 14. Global Pirfenidone Production Capacity (2017-2028) & (K Pcs)
Figure 15. Global Pirfenidone Production Capacity by Geographic Region: 2022 VS 2028
Figure 16. Pirfenidone Market Drivers
Figure 17. Pirfenidone Market Restraints
Figure 18. Pirfenidone Market Trends
Figure 19. Global Pirfenidone Sales Market Share by Manufacturer in 2021
Figure 20. Global Pirfenidone Revenue Market Share by Manufacturer in 2021
Figure 21. Pirfenidone Market Share by Company Type (Tier 1, Tier 2, and Tier 3) in 2021
Figure 22. Top 3 Pirfenidone Manufacturer (Revenue) Market Share in 2021
Figure 23. Top 6 Pirfenidone Manufacturer (Revenue) Market Share in 2021
Figure 24. Global Pirfenidone Sales Market Share by Region (2017-2028)
Figure 25. Global Pirfenidone Revenue Market Share by Region (2017-2028)
Figure 26. North America Pirfenidone Revenue (2017-2028) & (USD Million)
Figure 27. Europe Pirfenidone Revenue (2017-2028) & (USD Million)
Figure 28. Asia-Pacific Pirfenidone Revenue (2017-2028) & (USD Million)
Figure 29. South America Pirfenidone Revenue (2017-2028) & (USD Million)
Figure 30. Middle East & Africa Pirfenidone Revenue (2017-2028) & (USD Million)
Figure 31. Global Pirfenidone Sales Market Share by Type (2017-2028)
Figure 32. Global Pirfenidone Revenue Market Share by Type (2017-2028)
Figure 33. Global Pirfenidone Price by Type (2017-2028) & (USD/Pcs)
Figure 34. Global Pirfenidone Sales Market Share by Application (2017-2028)
Figure 35. Global Pirfenidone Revenue Market Share by Application (2017-2028)
Figure 36. Global Pirfenidone Price by Application (2017-2028) & (USD/Pcs)
Figure 37. North America Pirfenidone Sales Market Share by Type (2017-2028)
Figure 38. North America Pirfenidone Sales Market Share by Application (2017-2028)
Figure 39. North America Pirfenidone Sales Market Share by Country (2017-2028)
Figure 40. North America Pirfenidone Revenue Market Share by Country (2017-2028)
Figure 41. United States Pirfenidone Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 42. Canada Pirfenidone Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 43. Mexico Pirfenidone Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 44. Europe Pirfenidone Sales Market Share by Type (2017-2028)
Figure 45. Europe Pirfenidone Sales Market Share by Application (2017-2028)
Figure 46. Europe Pirfenidone Sales Market Share by Country (2017-2028)
Figure 47. Europe Pirfenidone Revenue Market Share by Country (2017-2028)
Figure 48. Germany Pirfenidone Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 49. France Pirfenidone Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 50. United Kingdom Pirfenidone Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 51. Russia Pirfenidone Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 52. Italy Pirfenidone Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 53. Asia-Pacific Pirfenidone Sales Market Share by Region (2017-2028)
Figure 54. Asia-Pacific Pirfenidone Sales Market Share by Application (2017-2028)
Figure 55. Asia-Pacific Pirfenidone Sales Market Share by Region (2017-2028)
Figure 56. Asia-Pacific Pirfenidone Revenue Market Share by Region (2017-2028)
Figure 57. China Pirfenidone Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 58. Japan Pirfenidone Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 59. Korea Pirfenidone Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 60. India Pirfenidone Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 61. Southeast Asia Pirfenidone Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 62. Australia Pirfenidone Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 63. South America Pirfenidone Sales Market Share by Type (2017-2028)
Figure 64. South America Pirfenidone Sales Market Share by Application (2017-2028)
Figure 65. South America Pirfenidone Sales Market Share by Country (2017-2028)
Figure 66. South America Pirfenidone Revenue Market Share by Country (2017-2028)
Figure 67. Brazil Pirfenidone Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 68. Argentina Pirfenidone Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 69. Middle East & Africa Pirfenidone Sales Market Share by Type (2017-2028)
Figure 70. Middle East & Africa Pirfenidone Sales Market Share by Application (2017-2028)
Figure 71. Middle East & Africa Pirfenidone Sales Market Share by Region (2017-2028)
Figure 72. Middle East & Africa Pirfenidone Revenue Market Share by Region (2017-2028)
Figure 73. Turkey Pirfenidone Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 74. Egypt Pirfenidone Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 75. Saudi Arabia Pirfenidone Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 76. South Africa Pirfenidone Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 77. Manufacturing Cost Structure Analysis of Pirfenidone in 2021
Figure 78. Manufacturing Process Analysis of Pirfenidone
Figure 79. Pirfenidone Industrial Chain
Figure 80. Sales Channel: Direct Channel vs Indirect Channel
Figure 81. Methodology
Figure 82. Research Process and Data Source
Please feel free to write an email to us or to use our electronic ticketing system.
